Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,287.70 +149.56 0.99%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,227.80 +47.03 0.91%

Tellabs CEO Rob Pullen Says He Is Being Treated for Cancer

Tellabs Inc. (TLAB) Chief Executive Officer Rob Pullen said he has been diagnosed with colon cancer and began chemotherapy a few weeks ago.

Pullen hasn’t shared what stage his cancer is in and continues working at the company full time, George Stenitzer, a spokesman for the Naperville, Illinois-based company, said in an interview. Pullen was named CEO of the networking equipment supplier in 2008, and has worked at the company since 1985.

Tellabs, which reported a loss of $188.4 million for 2011 citing economic uncertainty, appointed Andrew Szafran as chief financial officer this month. He succeeded Timothy Wiggins, who left the company in December to take a similar role at DeVry Inc. (DV) Tellabs is scheduled to report its first-quarter results on April 26.

“I am determined to fight it and beat it,” Pullen said in a statement today. “The doctors already are seeing some positive signs. My energy level is great.”

To contact the reporter on this story: Olga Kharif in Portland, Oregon, at okharif@bloomberg.net

To contact the editor responsible for this story: Jeran Wittenstein at jwittenstei1@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link